Dennis Mungall, PharmD; Richard White, MD
To the Editors: Gurwitz and coworkers (1) purport to show that the anticoagulant response to warfarin increases with age due to an "increased sensitivity" to warfarin; however, the ratio of warfarin dose to prothrombin time response used by the authors as the principal measure of sensitivity does not allow the differentiation of pharmacokinetic variability from pharmacologic sensitivity. In a prospective study of 88 chronically treated outpatients, we showed that age does not alter the pharmacodynamic response to warfarin (2).
The study by Shepard and coworkers (3), cited in dismissing a change in warfarin pharmacokinetics with age, was limited by a
Learn more about subscription options.
Register Now for a free account.
Mungall D, White R. Aging and Warfarin Therapy. Ann Intern Med. 1992;117:878–879. doi: 10.7326/0003-4819-117-10-878
Download citation file:
Published: Ann Intern Med. 1992;117(10):878-879.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only